Legend Biotech (LEGN) Leases (2019 - 2025)
Historic Leases for Legend Biotech (LEGN) over the last 7 years, with Q3 2025 value amounting to $142.3 million.
- Legend Biotech's Leases rose 4312.23% to $142.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $142.3 million, marking a year-over-year increase of 4312.23%. This contributed to the annual value of $101.9 million for FY2024, which is 2662.05% up from last year.
- Latest data reveals that Legend Biotech reported Leases of $142.3 million as of Q3 2025, which was up 4312.23% from $127.2 million recorded in Q2 2025.
- Legend Biotech's 5-year Leases high stood at $142.3 million for Q3 2025, and its period low was $7547.0 during Q1 2021.
- Its 5-year average for Leases is $72.7 million, with a median of $80.2 million in 2024.
- Per our database at Business Quant, Legend Biotech's Leases skyrocketed by 52687760.7% in 2022 and then crashed by 34.8% in 2024.
- Legend Biotech's Leases (Quarter) stood at $38.3 million in 2021, then skyrocketed by 45.21% to $55.6 million in 2022, then soared by 44.81% to $80.5 million in 2023, then grew by 26.62% to $101.9 million in 2024, then surged by 39.64% to $142.3 million in 2025.
- Its Leases was $142.3 million in Q3 2025, compared to $127.2 million in Q2 2025 and $107.2 million in Q1 2025.